Topical Dermatologic Corticosteroids In Vivo Bioequivalence - DRAFT Guidance
OtherFDA-2022-D-2170-0002
Comments
0
Awaiting comments
Deadline
Closed on Dec 24, 2022
Closed Dec 24, 2022
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- Topical Dermatologic Corticosteroids In Vivo Bioequivalence - DRAFT Guidance
- Posted
- Oct 24, 2022
- Comment period
- Oct 24, 2022 – Dec 24, 2022
Analysis
Overview
No comments yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.